April 15, 2021 | Thursday | News
New molecular diagnostics kit that uses self-collected saliva samples while ensuring diagnostic accuracy for specificity and sensitivity
Israel-based BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces on March 11, 2021, that it has launched a new molecular diagnostics kit that uses self-collected saliva samples to test for SARS-CoV-2 (COVID-19). Kits are expected to be delivered this month (April 2021). This CE-certified kit is able to detect all known variants of COVID-19 and asymptomatic cases.
These RT-PCR tests can maintain diagnostic accuracy by easing the sample collection method. The kit is part of Adaltis’ MOLgen product range. Saliva samples can be collected by an individual chewing a cotton ball for 30 seconds and then spitting it (or spitting directly) into a small plastic collector tube (Salivette). BATM claims that its RT-PCR technique will ensure the highest levels of diagnostic accuracy for both specificity and sensitivity. Currently, the available tests in the market use the lateral flow method, which is far less accurate causing many false negatives and positives.
Other benefits over the existing COVID-19 tests:
The non-invasive and self-assisted sample collection method is very beneficial while screening children, the elderly, and people with disabilities where the existing swabbing methods can cause distress. The rapid test can also be deployed at airports.
© Copyright 2024, MM Activ Sci-Tech Communications. All Rights Reserved.
Website Design & Developed By : SCI Knowledge Interlinks